| 000 | 01513 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516100751.0 | ||
| 264 | 0 | _c20121018 | |
| 008 | 201210s 0 0 eng d | ||
| 022 | _a1532-6535 | ||
| 024 | 7 |
_a10.1038/clpt.2012.66 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchildcrout, J S | |
| 245 | 0 | 0 |
_aOptimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _cAug 2012 |
||
| 300 |
_a235-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aDrug-Related Side Effects and Adverse Reactions _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPatient Safety |
| 650 | 0 | 4 |
_aPharmacogenetics _xmethods |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 700 | 1 | _aDenny, J C | |
| 700 | 1 | _aBowton, E | |
| 700 | 1 | _aGregg, W | |
| 700 | 1 | _aPulley, J M | |
| 700 | 1 | _aBasford, M A | |
| 700 | 1 | _aCowan, J D | |
| 700 | 1 | _aXu, H | |
| 700 | 1 | _aRamirez, A H | |
| 700 | 1 | _aCrawford, D C | |
| 700 | 1 | _aRitchie, M D | |
| 700 | 1 | _aPeterson, J F | |
| 700 | 1 | _aMasys, D R | |
| 700 | 1 | _aWilke, R A | |
| 700 | 1 | _aRoden, D M | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 92 _gno. 2 _gp. 235-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/clpt.2012.66 _zAvailable from publisher's website |
| 999 |
_c21900054 _d21900054 |
||